“Serum Visfatin as a Predictive Biomarker of Metabolic Dysregulation in Obesity: Correlation with Lipid Parameters and Insulin Resistance”, Bangladesh J Med Sci, vol. 25, no. 2, pp. 602–608, Apr. 2026, doi: 10.3329/bjms.v25i2.88747.